Dawei Chen

发表

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy

Yiqiang Liu, Jiafu Ji, Lianhai Zhang, 2013, Scientific Reports.

Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models

Ning Zhang, Shengyue Guo, Qi-xiang Li, 2017, Oncotarget.

Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model

Shengyue Guo, J. Wery, Linda Li, 2015, Oncotarget.

Cetuximab response in CRC patient-derived xenografts seems predicted by an expression based RAS pathway signature

J. Wery, Jie Cai, Xuesong Huang, 2016, Oncotarget.

A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations

J. Wery, Jie Cai, Xuesong Huang, 2015, Oncotarget.

Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor response.

J. Wong, Tai-guang Jin, N. Zhang, 2012, Journal of medicinal chemistry.

A subset of esophageal squamous cell carcinoma patient-derived xenografts respond to cetuximab, which is predicted by high EGFR expression and amplification.

Y. Nie, K. Zhao, H. Badakhshi, 2018, Journal of thoracic disease.

Prognosis of resectable colorectal liver metastases after surgery associated with pathological features of primary tumor

Dawei Chen, Qingshan Li, Haibo Yu, 2023, Frontiers in Oncology.

In Vivo Pharmacology Models for Cancer Target Research.

Demin Zhou, X. An, X. Ouyang, 2019, Methods in molecular biology.